Page 745 - Williams Hematology ( PDFDrive )

720 Part VI: The Erythrocyte Chapter 47: Erythrocyte Enzyme Disorders 721

459. Fischer TM, Meloni T, Pescarmona GP, et al: Membrane cross bonding in red cells in 489. Rochford R, Ohrt C, Baresel PC, et al: Humanized mouse model of glucose 6-phosphate
favic crisis: A missing link in the mechanism of extravascular haemolysis. Br J Haema- dehydrogenase deficiency for in vivo assessment of hemolytic toxicity. Proc Natl Acad
tol. 59:159–169, 1985. Sci U S A 110:17486–17491, 2013.
460. Caprari P, Bozzi A, Ferroni L, et al: Membrane alterations in G6PD- and PK-deficient 490. Ko CH, Li K, Li CL, et al: Development of a novel mouse model of severe glucose-6-
erythrocytes exposed to oxidizing agents. Biochem Med Metab Biol 45:16–27, 1991. phosphate dehydrogenase (G6PD)-deficiency for in vitro and in vivo assessment of
461. Johnson RM, Ravindranath Y, ElAlfy MS, et al: Oxidant damage to erythrocyte hemolytic toxicity to red blood cells. Blood Cells Mol Dis 47:176–181, 2011.
membrane in glucose-6-phosphate dehydrogenase deficiency: Correlation with in 491. Patrinostro X, Carter ML, Kramer AC, et al: A model of glucose-6-phosphate dehydro-
vivo reduced glutathione concentration and membrane protein oxidation. Blood 83: genase deficiency in the zebrafish. Exp Hematol 41:697–710 e692, 2013.
1117–1123, 1994. 492. Zhang P, Gao X, Ishida H, et al: An in vivo drug screening model using glucose-6-
462. Pantaleo A, Ferru E, Carta F, et al: Irreversible AE1 tyrosine phosphorylation leads to phosphate dehydrogenase deficient mice to predict the hemolytic toxicity of 8-amino-
membrane vesiculation in G6PD deficient red cells. PLoS One 6:e15847, 2011. quinolines. Am J Trop Med Hyg 88:1138–1145, 2013.
463. Kaplan M, Hammerman C: Severe neonatal hyperbilirubinemia. A potential compli- 493. Dern RJ, Beutler E, Alving AS: The hemolytic effect of primaquine. II. The natural
cation of glucose-6-phosphate dehydrogenase deficiency. Clin Perinatol 25:575–590, course of the hemolytic anemia and the mechanism of its self-limited character. J Lab
1998. Clin Med 44:171–175, 1954.
464. Kaplan M, Hammerman C: Glucose-6-phosphate dehydrogenase deficiency: A poten- 494. Beutler E, Dern RJ, Alving AS: The hemolytic effect of primaquine. III. A study of
tial source of severe neonatal hyperbilirubinaemia and kernicterus. Semin Neonatol primaquine-sensitive erythrocytes. J Lab Clin Med 44:177–184, 1954.
7:121–128, 2002. 495. Beutler E, Dern RJ, Alving AS: The hemolytic effect of primaquine. IV. The relationship
465. Kaplan M, Hammerman C: Glucose-6-phosphate dehydrogenase deficiency: A hidden of cell age to hemolysis. J Lab Clin Med 44:439–442, 1954.
risk for kernicterus. Semin Perinatol 28:356–364, 2004. 496. George JN, Sears DA, McCurdy P, et al: Primaquine sensitivity in caucasians: Hemolytic
466. Kaplan M, Hammerman C, Vreman HJ, et al: Severe hemolysis with normal blood reactions induced by primaquine in G6PD deficient subjects. J Lab Clin Med 70:80–93,
count in a glucose-6-phosphate dehydrogenase deficient neonate. J Perinatol 28: 1967.
306–309, 2008. 497. Siddiqui T, Khan AH: Hepatitis A and cytomegalovirus infection precipitating acute
467. Kaplan M, Renbaum P, Levy-Lahad E, et al: Gilbert syndrome and glucose-6-phosphate hemolysis in glucose-6-phosphate dehydrogenase deficiency. Mil Med 163:434–435,
dehydrogenase deficiency: A dose-dependent genetic interaction crucial to neonatal 1998.
hyperbilirubinemia. Proc Natl Acad Sci U S A 94:12128–12132, 1997. 498. Tugwell P: Glucose-6-phosphate-dehydrogenase deficiency in Nigerians with jaundice
468. Huang CS, Chang PF, Huang MJ, et al: Glucose-6-phosphate dehydrogenase deficiency, associated with lobar pneumonia. Lancet 1:968–969, 1973.
the UDP-glucuronosyl transferase 1A1 gene, and neonatal hyperbilirubinemia. Gas- 499. Choremis C, Kattamis CA, Kyriazakou M, et al: Viral hepatitis in G-6-PD deficiency.
troenterology 123:127–133, 2002. Lancet 1:269–270, 1966.
469. Oluboyede OA, Esan GJ: F., Francis TI, et al: Genetically determined deficiency of glu- 500. Walker DH, Hawkins HK, Hudson P: Fulminant Rocky Mountain spotted fever. Arch
cose 6-phosphate dehydrogenase (type A–) is expressed in the liver. J Lab Clin Med Pathol Lab Med 107:121–125, 1983.
93:783–789, 1979. 501. Huo TI, Wu JC, Chiu CF, et al: Severe hyperbilirubinemia due to acute hepatitis a super-
470. Kaplan M, Hammerman C, Maisels MJ: Bilirubin genetics for the nongeneticist: Hered- imposed on a chronic hepatitis B carrier with glucose-6-phosphate dehydrogenase defi-
itary defects of neonatal bilirubin conjugation. Pediatrics 111:886–893, 2003. ciency. Am J Gastroenterol 91:158–159, 1996.
471. Sanna S, Busonero F, Maschio A, et al: Common variants in the SLCO1B3 locus are 502. Chau TN, Lai ST, Lai JY, et al: Haemolysis complicating acute viral hepatitis in patients
associated with bilirubin levels and unconjugated hyperbilirubinemia. Hum Mol Genet with normal or deficient glucose-6-phosphate dehydrogenase activity. Scand J Infect Dis
18:2711–2718, 2009. 29:551–553, 1997.
472. Kaplan M, Hammerman C: Glucose-6-phosphate dehydrogenase deficiency and severe 503. Green L, De Lord C, Clark B, et al: Transient aplastic crisis as presentation of a previ-
neonatal hyperbilirubinemia: A complexity of interactions between genes and environ- ously unknown G6PD deficiency with iron overload. Br J Haematol 154:288, 2011.
ment. Semin Fetal Neonatal Med 15:148–156, 2010. 504. Garcia S, Linares M, Colomina P, et al: Cytomegalovirus infection and aplastic crisis in
473. Valentine WN, Paglia DE: The primary cause of hemolysis in enzymopathies of anaer- glucose-6-phosphate dehydrogenase deficiency. Lancet 2:105, 1987.
obic glycolysis: A viewpoint. Blood Cells 6:819–829, 1980. 505. Pietrapertosa A, Palma A, Campanale D, et al: Genotype and phenotype correlation in
474. Beutler E: “The primary cause of hemolysis in enzymopathies of anaerobic glycolysis: A glucose-6-phosphate dehydrogenase deficiency. Haematologica 86:30–35, 2001.
viewpoint.” A commentary. Blood Cells 6:827–829, 1980. 506. Kattamis CA, Kyriazakou M, Chaidas S: Favism. Clinical and biochemical data. J Med
475. Bogdanova A, Makhro A, Wang J, et al: Calcium in red blood cells-a perilous balance. Genet 6:34–41, 1969.
Int J Mol Sci 14:9848–9872, 2013. 507. Wong WY, Powars D, Williams WD: “Yewdow”-induced anemia. West J Med 151:
476. Ronquist G, Rudolphi O, Engström I, et al: Familial phosphofructokinase deficiency 459–460, 1989.
is associated with a disturbed calcium homeostasis in erythrocytes. J Intern Med 249: 508. Globerman H, Novak T, Chevion M: Haemolysis in a G6PD-deficient child induced by
85–95, 2001. eating unripe peaches. Scand J Haematol 33:337–341, 1984.
477. Sabina RL, Waldenström A, Ronquist G: The contribution of Ca+ calmodulin activa- 509. Williams CK, Osotimehin BO, Ogunmola GB, Awotedu AA: Haemolytic anaemia
tion of human erythrocyte AMP deaminase (isoform E) to the erythrocyte metabolic associated with Nigerian barbecued meat (red suya). Afr J Med Med Sci 17:71–75,
dysregulation of familial phosphofructokinase deficiency. Haematologica 91:652–655, 1988.
2006. 510. Schiliro G, Russo A, Curreri R, et al: Glucose-6-phosphate dehydrogenase deficiency
478. Aisaki K, Aizawa S, Fujii H, et al: Glycolytic inhibition by mutation of pyruvate kinase in Sicily. Incidence, biochemical characteristics and clinical implications. Clin Genet
gene increases oxidative stress and causes apoptosis of a pyruvate kinase deficient cell 15:183–188, 1979.
line. Exp Hematol 35:1190–1200, 2007. 511. Liu H, Liu W, Tang X, et al: Association between G6PD deficiency and hyperbiliru-
479. Youngster I, Arcavi L, Schechmaster R, et al: Medications and glucose-6-phosphate binemia in neonates: A meta-analysis. Pediatr Hematol Oncol 32:92–98, 2015.
dehydrogenase deficiency: An evidence-based review. Drug Saf 33:713–726, 2010. 512. Valaes T: Severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase
480. Campbell GD Jr, Steinberg MH, Bower JD: Ascorbic acid-induced hemolysis in G6PD deficiency: Pathogenesis and global epidemiology. Acta Paediatr 394:58–76, 1994.
deficiency. Ann Intern Med 82: 810, 1975. 513. Kaplan M, Hammerman C, Vreman HJ, et al: Acute hemolysis and severe neonatal
481. Rees DC, Kelsey H, Richards JD: Acute haemolysis induced by high dose ascorbic acid hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient heterozygotes.
in glucose-6-phosphate dehydrogenase deficiency. BMJ 306:841–842, 1993. J Pediatr 139:137–140, 2001.
482. Mehta JB, Singhal SB, Mehta BC: Ascorbic-acid-induced haemolysis in G6PD defi- 514. Fok TF, Lau SP: Glucose-6-phosphate dehydrogenase deficiency: A preventable cause of
ciency. Lancet 336:944–944, 1990. mental retardation. BMJ 292: 829, 1986.
483. Relling MV, McDonagh EM, Chang T, et al: Clinical Pharmacogenetics Implementa- 515. Singh H: Glucose-6-phosphate dehydrogenase deficiency: A preventable cause of men-
tion Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD tal retardation. BMJ 292:397–398, 1986.
deficiency genotype. Clin Pharmacol Ther 96:169–174, 2014. 516. Olusanya B, Emokpae A, Zamora T, et al: Addressing the burden of neonatal hyper-
484. McCaffrey RP, Halsted CH, Wahab MF, Robertson RP: Chloramphenicol-induced bilirubinaemia in countries with significant glucose-6-phosphate dehydrogenase defi-
hemolysis in Caucasian glucose-6-phosphate dehydrogenase deficiency. Ann Intern ciency. Acta Paediatr 103:1102–1109, 2014.
Med 74:722–726, 1971. 517. Ardati KO, Bajakian KM, Tabbara KS: Effect of glucose-6-phosphate dehydrogenase
485. Chan TK, Chesterman CN, McFadzean AJ, Todd D: The survival of glucose-6- deficiency on neutrophil function. Acta Haematol 97:211–215, 1997.
phosphate dehydrogenase-deficient erythrocytes in patients with typhoid fever on 518. Cooper MR, DeChatelet LR, McCall CE, et al: Complete deficiency of leukocyte
chloramphenicol therapy. J Lab Clin Med 77:177–184, 1971. glucose-6-phosphate dehydrogenase with defective bactericidal activity. J Clin Invest
486. Markowitz N, Saravolatz LD: Use of trimethoprim-sulfamethoxazole in a glucose-6- 51:769–778, 1972.
phosphate dehydrogenase-deficient population. Rev Infect Dis 9 Suppl 2:S218–S229, 519. Gray GR, Klebanoff SJ, Stamatoyannopoulos G, et al: Neutrophil dysfunction, chronic
1987. granulomatous disease, and nonspherocytic haemolytic anaemia caused by complete
487. Magon AM, Leipzig RM, Zannoni VG, et al: Interactions of glucose-6-phosphate dehy- deficiency of glucose-6-phosphate dehydrogenase. Lancet 2:530–534, 1973.
drogenase deficiency with drug acetylation and hydroxylation reactions. J Lab Clin Med 520. Vives-Corrons JL, Feliu E, Pujades MA, et al: Severe glucose-6-phosphate dehydro-
97:764–770, 1981. genase (G 6 PD) deficiency associated with chronic hemolytic anemia, granulocyte
488. Woolhouse NM, Atu-Taylor LC: Influence of double genetic polymorphism on dysfunction and increased susceptibility to infections. Description of a new molecular
response to sulfamethazine. Clin Pharmacol Ther 31:377–383, 1982. variant (G 6 PD Barcelona). Blood 59:428–434, 1982.

Kaushansky_chapter 47_p0689-0724.indd 720 9/17/15 6:45 PM